TRIM21 and interstitial lung disease: On the other hand, among the total number of patients with ILD (n = 123, 15.61%), the antibody most closely associated was anti-MDA5 (22.76%), followed by anti-Ro-52 (21.95%) and anti-SAE (21.95%).